Found: 9
Select item for more details and to access through your institution.
Germline Biallelic Mismatch Repair Deficiency in Childhood Glioblastoma and Implications for Clinical Management.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01219-x
- By:
- Publication type:
- Article
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1253629
- By:
- Publication type:
- Article
Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 13, p. 1095, doi. 10.1111/1759-7714.15281
- By:
- Publication type:
- Article
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in earlystage lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1758, doi. 10.1002/cncr.35263
- By:
- Publication type:
- Article
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1723, doi. 10.1002/cncr.34716
- By:
- Publication type:
- Article
Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 157, doi. 10.3390/cancers15010157
- By:
- Publication type:
- Article
TMOD-10. REPLICATION REPAIR DEFICIENT MOUSE MODELS PROVIDE INSIGHT ON HYPERMUTANT BRAIN TUMOURS AND COMBINATIONAL IMMUNOTHERAPY.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii123, doi. 10.1093/neuonc/noz036.248
- By:
- Publication type:
- Article
IMMU-20. IMMUNE AND TUMOR BIOMARKERS OF OUTCOME IN REPLICATION REPAIR DEFICIENT BRAIN TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: UPDATES FROM THE INTERNATIONAL REPLICATION REPAIR DEFICIENCY CONSORTIUM.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii96, doi. 10.1093/neuonc/noz036.139
- By:
- Publication type:
- Article